102 - Chronic Lung Disease: From Biomarkers to New Treatments

Friday, October 13, 2023

8:00 AM – 9:00 AM US ET

Location: 102 AB

All relevant financial disclosures have been mitigated.

Moderator(s)

Mahalia Desruisseaux, MD

Associate Professor
Yale School of Medicine
New Haven, CT, United States
Luiz Bermudez, MD

Professor
Oregon State University
Corvallis, OR, United States

Faculty(s)

Kevin Fennelly, MD, MPH (he/him/his)

Senior Research Physician
National Institutes of Health, NHLBI
Bethesda, MD, United States

Slides
Sanjay Sethi, Doctor of Medicine (he/him/his)

Professor of Medicine
University at Buffalo, SUNY
Buffalo, NY, United States

Slides

Disclosure(s):

Mahalia S. Desruisseaux, MD: No financial relationships to disclose

Luiz Bermudez, MD: No financial relationships to disclose

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit
CNE Credits: Maximum of 1 hours of ANCC Credit
ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the risks of infections in people of chronic lung conditions;
manage infections in individuals with COPD;
explain treatment and Prognostic of NTM in patients with chronic lung diseases

Presentations:

8:00 AM – 8:30 AM US ET

Diagnosis and Treatment of Pulmonary NTM Infections in Patients With Chronic Lung Diseases
Speaker: Kevin P. Fennelly, MD, MPH (he/him/his) – National Institutes of Health, NHLBI
8:30 AM – 9:00 AM US ET

Persistent Airway Infection in COPD
Speaker: Sanjay Sethi, Doctor of Medicine (he/him/his) – University at Buffalo, SUNY